Spots Global Cancer Trial Database for malignant gliomas
Every month we try and update this database with for malignant gliomas cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor | NCT02632370 | Malignant Gliom... | Gliolan® Fluorescence-Gu... | 18 Years - 80 Years | Icahn School of Medicine at Mount Sinai | |
| Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas | NCT02388659 | Malignant Gliom... Oligodendroglio... Astrocytomas | 3 Tesla scannin... | 18 Years - | University of Texas Southwestern Medical Center | |
| A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies | NCT02571036 | Gastrointestina... Advanced System... Advanced Cancer... | DCC-2618 DCC-2618 | 18 Years - | Deciphera Pharmaceuticals LLC | |
| Cetuximab, Bevacizumab and Irinotecan for Patients With Malignant Glioblastomas | NCT00463073 | Malignant Gliom... | Cetuximab Bevacizumab Irinotecan | 18 Years - | Rigshospitalet, Denmark | |
| Radiotherapy for Malignant Astrocytomas in the Elderly | NCT00430911 | Primary Brain T... Anaplastic Astr... Glioblastoma Mu... | Radiotherapy | 70 Years - | Assistance Publique - Hôpitaux de Paris | |
| Bevacizumab for Recurrent Malignant Glioma | NCT00271609 | Recurrent High-... Malignant Gliom... | Bevacizumab | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Imaging Study of Glioblastomas Treated With Avastin | NCT01549392 | Malignant Gliom... | DECT MR spectroscopy | 18 Years - 90 Years | London Health Sciences Centre | |
| Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas | NCT00610571 | Glioblastoma Gliosarcoma Anaplastic Astr... | Oral Topotecan ... | 18 Years - | Duke University | |
| Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I | NCT00671801 | Malignant Gliom... | Irinotecan Lenalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme: Phase I | NCT00671801 | Malignant Gliom... | Irinotecan Lenalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme | NCT00704288 | Glioblastoma Mu... | XL184 | 18 Years - | Exelixis | |
| Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas | NCT00822887 | Malignant Gliom... | Vandetanib Fractionated St... | 18 Years - | University of Colorado, Denver | |
| Clinical Development of Cancer-Specific MRS Biomarkers in Malignant Gliomas | NCT02388659 | Malignant Gliom... Oligodendroglio... Astrocytomas | 3 Tesla scannin... | 18 Years - | University of Texas Southwestern Medical Center | |
| Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00165477 | Glioblastoma Gliosarcoma Malignant Gliom... | lenalidomide Radiation | 18 Years - | Dana-Farber Cancer Institute | |
| Ph I Oral Topotecan and Temozolomide for Patients With Malignant Gliomas | NCT00610571 | Glioblastoma Gliosarcoma Anaplastic Astr... | Oral Topotecan ... | 18 Years - | Duke University | |
| Imaging Study of Glioblastomas Treated With Avastin | NCT01549392 | Malignant Gliom... | DECT MR spectroscopy | 18 Years - 90 Years | London Health Sciences Centre | |
| Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM) | NCT03018288 | Glioblastoma | Pembrolizumab HSPPC-96 Temozolomide Placebo Surgery | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Valproic Acid, Radiation, and Bevacizumab in Children With High Grade Gliomas or Diffuse Intrinsic Pontine Glioma | NCT00879437 | Glial Cell Tumo... Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... Gliomatosis Cer... Gliosarcoma Brainstem Gliom... Diffuse Intrins... | Valproic acid Bevacizumab Radiation thera... | 3 Years - 21 Years | Baylor College of Medicine | |
| ZD6474 to Treat Advanced Brain Cancer in Patients | NCT00272350 | Recurrent High-... Progressive Low... Malignant Gliom... | Steroids ZD6474 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas | NCT00704080 | Mixed Gliomas Malignant Gliom... Glioblastoma Mu... | XL765 (SAR24540... Temozolomide | 18 Years - | Sanofi | |
| 3D Ultra Sound for Resection of Brain Tumors | NCT02150564 | Patients With R... | Sonowand Navigation | 18 Years - | Tata Memorial Hospital | |
| Psychological Intervention for Caregivers of Patients With Malignant Gliomas | NCT03735498 | Malignant Gliom... | Psychological I... | 18 Years - | Massachusetts General Hospital | |
| Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas | NCT01966809 | Brain Tumor, Re... | Photofrin photo... | 18 Years - | Medical College of Wisconsin | |
| Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas | NCT00613223 | Gliosarcoma Glioblastoma | Vandetanib and ... | 18 Years - | Duke University | |
| 5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor | NCT02632370 | Malignant Gliom... | Gliolan® Fluorescence-Gu... | 18 Years - 80 Years | Icahn School of Medicine at Mount Sinai | |
| A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies | NCT02571036 | Gastrointestina... Advanced System... Advanced Cancer... | DCC-2618 DCC-2618 | 18 Years - | Deciphera Pharmaceuticals LLC | |
| Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients | NCT03212742 | Malignant Gliom... Radiotherapy PARP Inhibitor | Olaparib Temozolomide (T... IMRT (Intensity... | 18 Years - 70 Years | Centre Francois Baclesse | |
| ZD6474 to Treat Advanced Brain Cancer in Patients | NCT00272350 | Recurrent High-... Progressive Low... Malignant Gliom... | Steroids ZD6474 | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas | NCT00074646 | Glioblastoma Malignant Gliom... | CC-8490 | 18 Years - | Celgene | |
| Sunitinib to Treat Recurrent Brain Cancer | NCT00923117 | Glioblastoma Mu... Malignant Gliom... Anaplastic Glio... | Sutent (sunitin... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Vaccination-Dendritic Cells With Peptides for Recurrent Malignant Gliomas | NCT00766753 | Malignant Gliom... | Dendritic vacci... The first boost... The second boos... | 18 Years - | University of Pittsburgh | |
| ZD6474 to Treat Advanced Brain Cancer in Patients | NCT00272350 | Recurrent High-... Progressive Low... Malignant Gliom... | Steroids ZD6474 | 18 Years - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
